Aroa Biosurgery Limited (ASX:ARX) Share Price Rises 0.85% as Stock Trades Within Daily Range

Anjali Anand

13 August 2026 09:40 PM AEST

Aroa Biosurgery Limited (ASX:ARX) Share Price Rises 0.85% as Stock Trades Within Daily Range

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Aroa Biosurgery Limited (ASX:ARX) shares closed higher at $0.590 after gaining 0.854% during the session.
The stock traded within a bid and offer range of $0.580 to $0.600.
Trading Volume reached 43,656 shares during the session.
Market capitalisation stood at $202.35M based on the latest provided figures.
Aroa Biosurgery Limited was listed on the Australian Securities Exchange on 24 July 2020.

Overview

Aroa Biosurgery Limited (ASX:ARX) is listed on the Australian Securities Exchange and operates within the healthcare sector. The company is classified under the Pharmaceuticals, Biotechnology & Life Sciences industry group. This article provides an educational summary of the company’s latest available share price activity and market statistics based on the provided data.

The article focuses on available trading information, including share price movement, trading volume and market capitalisation. It is intended to provide a factual overview of market activity and does not represent financial advice or a recommendation regarding the company’s shares.

Share Price Movement

Shares of Aroa Biosurgery Limited (ASX:ARX) closed at $0.590, representing an increase of $0.005 or 0.854% compared with the previous trading level based on the latest provided data.

During the session, the stock traded within a bid and offer range between $0.580 and $0.600. This range reflects the quoted buying and selling levels available during the reported period.

The daily movement of a Listed security reflects changes in market participation and trading activity during a specific session. A single trading period represents short-term price activity and does not indicate the complete performance history of a company.

Trading Volume and Market Capitalisation

Aroa Biosurgery Limited recorded trading volume of 43,656 shares during the session. Trading volume represents the number of shares exchanged between buyers and sellers during a particular trading period and is commonly reviewed alongside share price movements.

The company’s Market Capitalisation was recorded at $202.35M based on the latest provided market data. Market capitalisation represents the total Market Value of a company’s Issued Shares and is calculated using the share price and the number of shares on issue.

Trading volume and market capitalisation provide an overview of the company’s current market position based on available information at a specific point in time.

Share Information and Trading Details

Aroa Biosurgery Limited was listed on the Australian Securities Exchange on 24 July 2020. The provided information does not include the company’s daily trading range, previous close, average volume, 52-week range or shares on issue.

The bid and offer range was recorded between $0.580 and $0.600, representing the available quoted buying and selling levels during the trading session.

Market statistics such as share price movement, trading activity and market capitalisation provide a snapshot of the company’s market position during the reported period.

Healthcare Sector Context

Aroa Biosurgery Limited is categorised within the healthcare sector, specifically under the Pharmaceuticals, Biotechnology & Life Sciences industry group. Companies within this category may operate across healthcare-related activities, including biotechnology, medical products and life sciences.

Individual share price movements can be influenced by company-specific developments, market participation and broader market conditions. A single Trading session reflects short-term market activity and represents only one point in a company’s broader trading history.

Conclusion

In summary, Aroa Biosurgery Limited (ASX:ARX) shares closed at $0.590 after recording a gain of 0.854% during the latest reported session. The stock recorded trading activity of 43,656 shares and a market capitalisation of $202.35M based on the provided information. The available market statistics provide an educational overview of the company’s latest trading position and should be considered as a snapshot of market activity at the reported time.

Frequently Asked Questions (FAQs)

FAQs

Q: What was the latest share price of Aroa Biosurgery Limited (ASX:ARX)?

A:Aroa Biosurgery Limited (ASX:ARX) was recorded at $0.590 based on the latest provided market data.

Q: How much did ARX shares increase during the session?

A:The share price increased by $0.005, representing a gain of 0.854%.

Q: What was the trading volume for Aroa Biosurgery Limited?

A:The trading volume for the session was recorded at 43,656 shares.

Q: What was the market capitalisation of Aroa Biosurgery Limited?

A:The company’s market capitalisation was recorded at $202.35M based on the provided figures.

Q: When was Aroa Biosurgery Limited listed?

A:Aroa Biosurgery Limited was listed on 24 July 2020.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.